NHSPI_measure_metadata: 98

This data as json, copyable

rowid	obsid	index	item_code	domain_code	domain_name	domain_description	subdomain_code	subdomain_name	subdomain_description	subdomain_long_desc	measure_name	measure_description	measure_rationale	data_source	verbose_data_source	data_dates	limitations
98	224.0	Index	5.2.1	5.0	CM	Countermeasure Management	16.0	CUE	Countermeasure Utilization & Effectiveness	The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention.	M24	Percent of children ages 19-35 months in the state receiving recommended routine childhood vaccinations, including four or more doses of diphtheria, tetanus, and pertussis vaccine, three or more doses of poliovirus vaccine, one or more doses of any measles-containing vaccine, and three or more doses of Hepatitis B vaccine	The measure is used by the Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of achievement of immunization program objectives. The measure is a pre-event indicator of the capacity of the state's public and private immunization infrastructure needed to respond to an emerging vaccine-controllable disease.	CDC NIS	Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHC), National Immunization Survey (NIS)	2012—2017	The measure evaluates routine vaccines for preventable disease in pre-school age children, and may not reflect the vaccination rate for a severe emerging disease.